Electromed

OverviewSuggest Edit

Electromed, Inc. develops, manufactures, markets and sells innovative products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

The SmartVest System generates HFCWO, also known as High-Frequency Chest Compression, a technique for airway clearance therapy. The garment repeatedly compresses and releases the upper body at frequencies from 5 to 20 cycles per second creating a “mini cough”. Each compression (or oscillation) produces pulsations that thin and loosen secretions from the surfaces of the lung airways, thins mucus stuck in the lungs and propels them toward the mouth where they can be removed by normal coughing or suction.

TypePublic
Founded1992
HQNew Prague, MN, USMap
Websitesmartvest.com
View Jobs

Recent NewsAll News

Latest Updates

Employees (est.) (Jun 2019)119(-9%)
Revenue (FY, 2020)$32.5 M(+4%)
Share Price (Jul 2021)$11.6(-2%)
Cybersecurity ratingAMore

Key People/Management at Electromed

Kathleen Skarvan

Kathleen Skarvan

President & Chief Executive Officer
Mike MacCourt

Mike MacCourt

Chief Financial Officer
Kristine Owata

Kristine Owata

Vice President of Reimbursement & Payer Relations
Show more

Electromed Office Locations

Electromed has an office in New Prague
New Prague, MN, US (HQ)
500 6th Ave NW
Show all (1)

Electromed Financials and Metrics

Electromed Revenue

Embed Graph
View revenue for all periods
Electromed's revenue was reported to be $32.47 m in FY, 2020
USD

Revenue (Q3, 2021)

8.8m

Gross profit (Q3, 2021)

6.7m

Gross profit margin (Q3, 2021), %

76.3%

Net income (Q3, 2021)

223.8k

EBIT (Q3, 2021)

243.0k

Market capitalization (29-Jul-2021)

99.9m

Closing stock price (29-Jul-2021)

11.6

Cash (31-Mar-2021)

12.5m

EV

87.4m
Electromed's current market capitalization is $99.9 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Revenue

19.5m15.1m15.5m19.4m23.0m25.9m28.7m31.3m32.5m

Revenue growth, %

25%18%

Cost of goods sold

5.4m4.7m4.9m5.8m5.1m5.3m5.8m7.5m7.3m

Gross profit

14.1m10.4m10.6m13.6m17.9m20.6m22.9m23.8m25.2m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021Q3, 2021

Revenue

5.4m4.8m4.8m4.0m3.9m3.2m3.4m3.5m4.0m4.8m4.9m4.6m5.0m6.3m6.0m5.5m6.4m6.7m6.4m7.0m7.1m7.3m8.0m7.4m8.3m8.5m8.7m9.5m8.8m

Cost of goods sold

1.3m1.3m1.4m1.2m1.3m756.7k1.1m978.0k1.4m1.5m1.5m1.4m1.1m1.4m1.4m1.2m1.4m1.4m1.4m1.4m1.5m1.7m2.0m1.8m2.0m1.9m2.2m2.0m2.1m

Gross profit

4.1m3.5m3.4m2.8m2.5m2.4m2.4m2.5m2.5m3.3m3.4m3.2m3.9m4.9m4.6m4.3m4.9m5.3m4.9m5.6m5.6m5.5m6.1m5.6m6.3m6.7m6.6m7.5m6.7m

Gross profit Margin, %

75%73%71%70%65%76%69%72%64%69%70%69%77%78%77%78%77%80%77%80%79%76%76%75%76%78%75%79%76%
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Cash

1.7m503.6k1.5m3.6m5.1m5.6m7.5m7.8m10.5m

Accounts Receivable

10.9m9.0m6.5m6.5m7.6m9.9m11.6m12.8m12.9m

Prepaid Expenses

359.6k428.8k397.9k397.8k393.3k832.2k353.2k353.3k

Inventories

2.4m1.4m2.2m2.1m2.5m2.6m2.4m2.6m3.1m
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021Q3, 2021

Cash

2.9m1.7m1.4m1.5m1.0m505.0k1.1m1.2m772.4k2.3m2.5m2.9m3.8m4.5m4.9m3.8m4.8m5.4m5.8m6.8m7.1m7.7m7.2m7.5m8.0m9.2m9.9m11.7m12.5m

Accounts Receivable

10.4m10.7m11.1m10.4m9.7m9.2m8.0m7.0m6.5m6.4m6.6m6.4m6.5m6.9m7.3m8.0m8.3m8.9m9.6m9.7m10.1m11.5m11.9m12.3m12.7m12.7m13.3m15.4m16.2m

Prepaid Expenses

419.2k467.0k515.0k463.4k358.9k465.0k460.9k298.6k448.3k485.7k372.2k481.5k501.0k341.5k442.6k497.4k425.9k492.0k565.9k379.7k483.8k415.5k329.3k400.8k476.1k313.4k361.0k381.8k483.4k

Inventories

2.2m2.4m2.4m2.3m1.9m2.1m1.4m2.3m2.6m2.2m2.2m2.4m2.2m2.4m2.3m2.6m2.6m2.6m2.5m2.4m2.2m2.8m2.7m2.7m2.7m2.7m2.6m2.6m2.3m
show all
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020

Net Income

186.6k(1.3m)(1.3m)1.1m2.2m2.2m1.9m2.0m4.2m

Depreciation and Amortization

408.6k459.8k695.5k736.2k738.7k755.1k790.0k925.2k738.2k

Inventories

(536.5k)1.0m(855.9k)163.4k(347.6k)(28.3k)234.6k(106.2k)(449.3k)

Accounts Payable

(58.6k)(77.8k)(302.3k)384.0k873.8k(337.5k)556.0k(2.6k)(472.6k)
Quarterly
USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q2, 2021Q3, 2021

Net Income

245.5k270.1k365.2k(71.1k)(482.3k)(913.3k)(335.4k)(574.7k)(1.6m)377.5k800.2k837.5k341.0k1.4m1.9m191.2k635.0k1.3m121.1k470.4k783.2k154.4k532.1k882.3k1.0m2.2m2.9m1.7m2.0m

Depreciation and Amortization

90.6k193.8k300.2k115.0k231.9k344.7k154.5k322.3k504.7k186.2k370.2k557.2k185.5k369.1k550.7k186.5k373.0k563.6k192.3k386.3k581.0k164.7k389.8k617.2k180.9k379.2k560.6k315.6k358.7k

Inventories

(307.8k)(541.7k)(556.0k)87.1k493.4k251.0k(52.6k)(887.1k)(1.2m)(7.7k)1.0k(166.4k)(67.1k)(290.6k)(220.4k)(100.6k)(53.9k)(65.6k)115.6k183.6k373.4k(349.4k)(242.5k)(205.5k)(118.5k)(19.4k)(13.9k)490.4k838.7k

Accounts Payable

(40.8k)(343.1k)(296.2k)(347.2k)(75.0k)5.1k161.1k407.3k184.3k314.9k74.0k319.7k(171.3k)151.1k583.6k(1.2m)(807.2k)(323.5k)(36.9k)(149.6k)(55.0k)(103.3k)(233.8k)(63.8k)(250.0k)(427.4k)136.4k494.4k1.2m
show all
USDQ1, 2012

Debt/Equity

0.1 x

Debt/Assets

0.1 x

Financial Leverage

1.4 x
Show all financial metrics

Electromed Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

Learn more about our premium products
SecurityScorecard logo

Electromed Online and Social Media Presence

Electromed's Trends

Embed Graph

Electromed News and Updates

May 09, 2018

Electromed's (ELMD) CEO Kathleen Skarvan on Q3 2018 Results - Earnings Call Transcript

Electromed Blogs

October 26, 2020

Respiratory Care Week – October 25-31, 2020

Respiratory Care Week is an annual event to recognize the essential work and dedication of respiratory care professionals around the globe. Not only are they deserving of this recognition for the incredible work they do, but it is also a time to spread awareness about respiratory health. This year, …
October 09, 2020

How To Reduce Inflammation and Other Common Symptoms of Bronchiectasis

Living with bronchiectasis can cause a loved one to produce a chronic cough, experience shortness of breath, and develop frequent respiratory infections that could damage the lungs. Another common symptom of bronchiectasis is chronic inflammation, which can make breathing more difficult and further …
September 11, 2020

Finding Emotional Support for Your Chronic Respiratory Illness

Living with a chronic respiratory illness like COPD (chronic obstructive pulmonary disease), bronchiectasis, or an overlapping of the two conditions can take a toll on your mental health. You may feel isolated from the hobbies you enjoy doing, as well as the people you love spending time with. Thoug…
August 17, 2020

What Is a COPD Flare Up?

 A COPD flare up (also known as an COPD exacerbation) is a sudden worsening of symptoms that can leave you feeling low on energy, short on breath, or tightness in the chest area. Other common symptoms of COPD that may worsen during a flare up include[1]: Chronic cough Mucus Build up Respiratory infe…
July 24, 2020

What You Need to Know for COPD Nursing Care

COPD (chronic obstructive pulmonary disease) affects millions of Americans each year.[1] And because there are different types of COPD that can cause individuals to experience symptoms in many ways, understanding which conditions are associated with your patients’ pulmonary disease can help to provi…
July 20, 2020

Will I Need Oxygen Therapy for COPD?

COPD (chronic obstructive pulmonary disease) is an umbrella term used to describe multiple pulmonary conditions, like “…chronic bronchitis, emphysema, and irreversible, or refractory asthma”[1] and can cause individuals to experience fatigue, mucus buildup, wheezing, and breathlessness.[2] Depending…
Show more

 Electromed Frequently Asked Questions

  • When was Electromed founded?

    Electromed was founded in 1992.

  • Who are Electromed key executives?

    Electromed's key executives are Kathleen Skarvan, Mike MacCourt and Kristine Owata.

  • How many employees does Electromed have?

    Electromed has 119 employees.

  • What is Electromed revenue?

    Latest Electromed annual revenue is $32.5 m.

  • What is Electromed revenue per employee?

    Latest Electromed revenue per employee is $272.9 k.

  • Who are Electromed competitors?

    Competitors of Electromed include Hill-Rom Holdings, Vesiflo and TruHearing.

  • Where is Electromed headquarters?

    Electromed headquarters is located at 500 6th Ave NW, New Prague.

  • Where are Electromed offices?

    Electromed has an office in New Prague.

  • How many offices does Electromed have?

    Electromed has 1 office.